What Is Hidden Behind Yellow Pixels: from Pathology to Intravascular Imaging of Atherosclerotic Plaque.


Journal

Current atherosclerosis reports
ISSN: 1534-6242
Titre abrégé: Curr Atheroscler Rep
Pays: United States
ID NLM: 100897685

Informations de publication

Date de publication:
02 2022
Historique:
accepted: 10 10 2021
pubmed: 3 2 2022
medline: 6 5 2022
entrez: 2 2 2022
Statut: ppublish

Résumé

Intravascular imaging systems can identify lipid-rich and vulnerable plaques and help in treatment guidance. The comparability of different intracoronary imaging methods remains unclear. In this paper, we review atherosclerotic plaque pathology, plaque-stabilising effects of different lipid-lowering therapies and usage of intravascular imaging modalities. We present the results of our study in which we evaluated the correlation of the intravascular ultrasound iMAP system (iMAP-IVUS) and near-infrared spectroscopy (NIRS) in the diagnosis of vulnerable coronary plaques. Lipids have an essential contribution to plaque evolution and vulnerability. Increase in plaque vulnerability alone even without increase in plaque burden defines progression of atherosclerosis. Lipidic tissue has a significant diagnostic value in patient risk stratification and can serve as a treatment target. Different vulnerable plaque parameters can be visualised with iMAP-IVUS and NIRS. Intravascular imaging systems can differ with regard to their sensitivity, specificity and limitations. Lipid-lowering therapy is crucial in plaque stabilisation.

Identifiants

pubmed: 35107762
doi: 10.1007/s11883-022-00990-3
pii: 10.1007/s11883-022-00990-3
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-108

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Karlis Trusinskis (K)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia. karlistrusinskis@gmail.com.
Riga Stradins University, Dzirciema Street 16, Riga, 1007, Latvia. karlistrusinskis@gmail.com.

Evija Knoka (E)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.
Riga Stradins University, Dzirciema Street 16, Riga, 1007, Latvia.

Laima Caunite (L)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.
Riga Stradins University, Dzirciema Street 16, Riga, 1007, Latvia.

Mairita Karantajere (M)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.

Maris Lapsovs (M)

Riga Stradins University, Dzirciema Street 16, Riga, 1007, Latvia.

Sandra Paeglite (S)

Riga Stradins University, Dzirciema Street 16, Riga, 1007, Latvia.

Ieva Briede (I)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.

Karlis Grikis (K)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.
University of Latvia. Raina Bulvaris 19, Riga, 1050, Latvia.

Sanda Jegere (S)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.

Indulis Kumsars (I)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.

Inga Narbute (I)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.

Rudolfs Roze (R)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.

Dace Sondore (D)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.

Andrejs Erglis (A)

Latvian Centre of Cardiology, Pauls Stradins Clinical University Hospital, Pilsonu Street 13, Riga, 1002, Latvia.
University of Latvia. Raina Bulvaris 19, Riga, 1050, Latvia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH